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Liver Transplantation-1978 
T. E. Starzl. L. J. Koep, C. G. Halgrimson, J. Hood. G. P. J. Schroter. 
K. A. Porter, and R. Weillll 
I N THE 2 years since the last meeting of 
this Society, the prospects in liver trans-
plantation have improved. Thus, the following 
remarks will focus mainly on recent history. 
In so doing, they will also emphasize some 
troubling questions that remain in this field. 
Most of these unresolved issues in liver trans-
plantation have been developed from two 
large series: one, our own, and the other, that 
originated from the combined Cambridge-
King's College effort in England. Other work-
ers throughout the world have had less exten-
sive and, for the most part, unreported experi-
ence that we have not been able to accurately 
compile for this meeting. 
WHY HAS LIVER REPLACEMENT 
BEEN SO DANGEROUS? 
For a long time, the high acute mortality 
after liver transplantation made the proce-
dure profoundly experimental. Between 
March 1963 and July 1976, we treated I 1 I 
consecutive recipients of orthotopic liver 
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grafts. Of these, only 31 (28%) survived for as 
long as a year (Table 1). The rate of chronic 
survival improved only slightly during this 
time. Among the first 50 recipients in this 
original series of Ill, there were II (22%) 
who lived for as long as a year. Among the 
next 61 patients, there were 20 (33%) who 
survived for I year. 
Of the 31 I-year survivors, 16 died subse-
quently for reasons that are considered in 
another article in this issue.' The late deaths 
were after 12 months-6 years. 
Fifteen of the original I) I patients remain 
alive today with follow-ups of 22/ 3-82/3 years. 
Twelve of the 15 are now more than 4 years 
postoperative, and 7 are more than 5 years. 
Since I of the 16 late deaths was a patient 
who lived for 6 years, our center has so far 
had 13 liver recipients who survived in excess 
of 4 years and 8 who lived more than 5 
years. 
The details of all our cases, the indications 
for operation, and most importantly the 
reasons for the high acute mortality have been 
described elsewhere.2.3 The major causes of 
early death were technical misadventures, 
including biliary tract complications, vascular 
accidents of the homograft blood supply, 
hemorrhage, and the use of livers damaged by 
ischemia. In addition, many postoperative 
problems were caused by high-dose immuno-
suppression in patients who were incorrectly 
diagnosed as having rejection but who 
actually had other problems, such as biliary 
obstruction, cholangitis, and hepatitis. 
Because of these findings and conclusions, 
surgical and management changes were insti-
tuted in the summer of 1976. Microvascular 
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Table 1. Total Number of Patients March 1963 Through 
July 1976lFollow-Up to September 1.1978) 
Total 111 
31 (28'l1,)t Lived > 1 year 
Alive Now' 15 (after O~-U~ years) 
• The 16 late deaths were after 1-6 years. 
t With patients < 18 year. old. '·year survival was 
21/61 (34%). Among adults. I-year survival was 10/50 
(20'lI0). 
techniques were increasingly employed for 
vascular and often for biliary tract anasto-
moses, particularly in pediatric recipients. 
Postoperative hepatic dysfunction was not so 
easily ascribed to rejection. Instead, frequent 
liver biopsies were obtained and cholangi-
ography (transhepatic, T-tube, or retrograde 
endoscopic) became routine if the explanation 
of postoperative jaundice was not obvious. 
A new series was begun in July 1976, and 
completed in December 1977. Thirteen of the 
next 30 patients are alive, II beyond a year 
(Table 2). A fourteenth recipient, a child, 
died at 23 months of a sudden overwhelming 
infection. A fifteenth patient died after 161/ 2 
months with chronic rejection and portal vein 
thrombosis. Although 2 of the survivors are 
not quite I-year postoperative, they are well. 
Thus, the I-year survival in this most re-
cent experience is almost certain to be 50% 
(Table 2). 
There has been a similar improvement in 
the Cambridge-King's College units man-
aged by Caine and Williams. respectively.· 
Among the first 35 recipients treated by the 
bng~ish groups, there were only 3 I-year 
survIvors, but among the next 39 patients, 9 
have already lived more than a year and 6 
more are alive with shorter follow-ups.· 
Table 2. Uver Transplantation August 1978 Through 
December 1977IFollow·Up to September 1.1978) 
30' 
13t 
17* 
"With patients < 18 years old. "year survival i, 
projected .t 7/12 (58%). With adults. l-year survival i, 8/18 
(44%). 
tTwo of the .. patienta .,. postoperative 9 and 10 
months. respectively. 
*One death wa. at 23 months. another lit 6'h months. 
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Throughout the English series, as in ours, the 
role of purely technical surgical com plica tions 
has been emphasized. The quality of homo-
grafts used in England and in the United 
States has reached parity since the accep-
tance in Britain of brain death. 
HOW SHOULD THE BILIARY TRACTS BE 
RECONSTRUCTED? 
Realization that the biliary tract was the 
Achilles' heel of liver transplantation has 
prompted major reforms both at our center 
and in England. We believe that the ideal 
form of reconstruction is choledochocholedo-
chostomy using aT-tube stent (Fig. IA). A 
postoperative retrograde endoscopic cholan-
giogram obtained 4 months postoperatively 
after this kind of reconstruction is shown in 
Fig. 2. This patient will require repeat cholan-
giography every 4 or 6 months until the 
significance of the nonobstructing stricture 
can be determined with certainty. The neces-
sity of careful late follow-up has been illus-
trated by our own experience. whereby biliary 
obstruction has led to the death of several 
patients or required reoperation as long as 6 
years after the original transplantation. I - J 
Choledochocholedochostomy is often not 
feasible and as alternatives we perform chole-
cystojejunostomy or choledochojejunostomy 
to a Roux limb (Fig. I B and C). The ad-
vantage of cholecystojejunostomy is that the 
anastomosis is of a large caliber even in 
pediatric recipients and requires no stenting 
or drainage. The disadvantage is that obstruc-
tion to the cystic duct has necessitated reoper-
ation and conversion to choledochojejunos-
to my (Fig. ] B to Fig. I C) in 200/0--35% of the 
cases. Furthermore, the Roux limb or the 
jejunostomy below it have developed perfora-
. . s tlOns 10 several patients. This complication 
has carried a high mortality. 
Caine and his associates have advocated 
that the common duct and gallbladder be 
made into a common chamber with anasto-
~osis of the gallbladder fundus to the recip-
Ient common duct (or sometimes to a Roux 
limb).' The anastomosis is stented with a 
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Fig. 1. Techniques of biliary duct recon.tructlon acceptable to UI for mOlt tranlplantatlon reclplentl. (A) Choledo-
chocholedochostomy. Note that the T-tube II placed, If pOlllble, In recipient common duct. (BI Cholecy.tojelunoltomy. 
(CI Choledocholelunoatomy atter removal of gallbladder. 
T-tube, enabling the biliary system to be 
frequently studied or irrigated. They have 
been satisfied with this procedure·" and with 
it. biliary tract complications have been 
substantially reduced. Experience alone will 
tell if this somewhat more complicated 
approach is necessary or desirable . 
WHAT ARE APPROPRIATE INDICATIONS 
FOR LIVER TRANSPLANTATION? 
Anyone with chronic end-stage liver 
disease who is less than 45 or 50 years old, 
who is not infected, who has a hopeless 
prognosis, and who does not have widespread 
Fig. 2. Cholangiogram obtained 4 monthl pOltoperatIYely by the retrograde endolcoplc technique. Reconltructlon 
wa. with choledochocholedochoetomy (Fig. 1A). The T·tube wa. removed by the patient after 1 month. Note thelow-grade 
ana.tomotlc .trlcture (arrow). 
---~----------K 
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malignancy is a potential candidate for liver 
transplantation. However, there are impor-
tant differences in the attitudes of the 
Cambridge-King's College and American 
physicians and surgeons. For example, the 
English team does not perform the procedure 
on pediatric recipients. Besides their diffi-
culty in obtaining pediatric livers, they are 
concerned with the growth retardation that is 
predictable if long-term high-dose steroid 
therapy is necessary. Our own experience 
with infants and children has actually been 
better than with adults (Tables 1 and 2). 
Thus, we consider the pediatric recipient to be 
favored. 
Another major difference between the 
English and Colorado series is the high 
proportion of cirrhotics in our experience. 
Among the 68 adults treated by us from 1963 
through 1977, 45 have had Laennec's cirrho-
sis or chronic aggressive hepatitis. The diffi-
culty of the operations in some of these 
patients in our hands is hard to describe. The 
procedures may last for 12-18 hours and may 
necessitate the use of dozens of liters of blood. 
Nevertheless, we have continued to treat 
these patients, believing that this is where the 
most important future application of liver 
transplantation lies. From a technical point of 
view, the adult patient with primary biliary 
cirrhosis is ideal. They do not have severe 
portal hypertension, and their diseased livers 
are so soft and compliant that the technique is 
almost comparable in simplicity to that in 
normal animals. 
We have been increasingly disenchanted 
with the use of liver transplantation for 
primary hepatic malignancy. Eight of our 9 
patients who have survived 3 months or more 
after liver replacement for hepatomas, duct-
cell carcinomas, cholangiocarcinoma, and 
angiosarcoma have eventually developed re-
currence. One of our patients with duct-cell 
carcinoma died of metastases more than 2 
years later, and another one is alive 4 years 
postoperatively but with known recurrence. A 
third patient is still alive almost 2 years 
postoperatively with known metastases from a 
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sclerosing cholangiocarcinoma. The only pa-
tient cured of a hepatic malignancy by us was 
a child who had a small incidental hepatoma 
in her liver that was removed for the indica-
tion of biliary atresia rather than because of 
the unsuspected hepatoma. She is now 82/3 
years postoperative. 
A high incidence of recurrence has also 
been reported from Cambridge-King's Col-
lege (about 70% in those with extended 
survival). However, their view of liver 
replacement for hepatic malignancy is more 
optimistic than ours, particularly with respect 
to hepatomas.4.J Like us, they have uniformly 
had recurrence for duct-cell carcinomas. 
However the picture is stated, the yield from 
liver replacement for primary hepatic malig-
nancy is apt to be limited since the eventual 
outcome is so heavily weighted by the biologic 
behavior of the original lesion. 
Parenthetically, another difference be-
tween the Colorado and Cambridge series has 
been our use of antilymphocyte (or antithy-
mocyte) globulin for immunosuppression 
(Fig. 3). Both groups use azathioprine, cyclo-
phosphamide (on occasion), and prednisone. 
HOW EFFECTIVE IS PRESERVATION? 
Short-interval preservation techniques 
have had extensive trials in England and in 
Colorado with the shipment of livers from city 
to city. The Cambridge-King's College team 
has used a plasma solution for cold infusion of 
the homografts,· and we have employed 
Collins solution.9 In dogs, the two approaches 
yield comparable results and permit safe pres-
ervation for up to 12 hr. The same has been 
achieved in humans. 
McMaster, Caine, et al. 10 have drawn 
attention to the possible selective injury of 
biliary ducts with such techniques. They 
suspect that ischemia or perhaps the bile left 
within the major ducts or even the minor 
intrahepatic ones may cause autolysis and set 
the stage for later serious mechanical difficul-
ties. They have advocated much more thor-
ough washing of the biliary tree than has been 
generally practiced. 
l 
=" 
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Fig. 3. The cour.e of a patient treated with thoracic duct drainage after orthotopic liver tran.plantatlon for prlmery 
biliary cirrhosis. Note that azathioprine, prednllone, and antlthymocyte globulin (ATG) provided basic Immunosuppre.-
lion. The two rejecllons were mild and easily controlled with .terold •. 
WHAT IS THE ROLE OF TISSUE TYPING? 
It has never been possible to give typing 
techniques a fair trial in liver transplantation. 
Almost all of the matches in our series have 
been bad ones. For example, in the last 100 
Colorado cases only 2 patients have received 
livers with 3 or 4 antigen matches. It is 
unlikely that shopping for well-matched livers 
will be possible in the near future, since the 
need for transplantation is so pressing in 
appropriate candidates that it is obligatory to 
proceed with the first available organ. 
Because of this, a number of liver trans-
plantations have been performed despite the 
presence in the recipients of cytotoxic anti-
bodies that are anti-donor-specific. We have 
carried out 10 liver transplantations under 
these circumstances. There have been no 
examples of hyperacute rejection and, in fact, 
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Table 3. Positive Cytotoxic Crossmatche, 
Number of cases 
Hyperacute rejection 
Survival> 2 months 
Survival;;:" 6 months 
10' 
o 
7 
5t 
'OT 58. 63. 71A. 101. 114. 119.122.1038.138.151. 
t Longest survival-2 years. 
no demonstrable harmful effects have been 
seen at a later time (Table 3). Seven of the 
patients lived for more than 2 months and 5 
for more than 6 months. We and CaIne and 
Williams have concluded that the liver is 
highly privileged, at \east in confrontations 
with preformed cytotoxic antibody states. 
On the other hand, recent experience has 
made us uneasy about breaching blood group 
barriers. We have been forced to do this on 11 
occasions (Table 4). The livers did not func-
tion well in two of the recipients leading to 
death or retransplantation. The blood viola-
tions were B to 0 and B to A. The excised 
livers had superficial infarcts and focal necro-
sis. In desperation we still perform transplan-
tation despite blood group incompatibility, 
but we avoid doing this if possible. Except in 
the two exceptional cases, the other patients 
have not seemed to have been harmed 
(Table 4) by hyperacute rejection. 
IS THERE A NEED FOR BETTER 
IMMUNOSUPPRESSION? 
With such strong emphasis on nonimmuno-
logic factors as causes of failure after liver 
transplantation (see earlier), it might be 
erroneously concluded that immunosuppres-
sion is satisfactory. In fact, much remains to 
be learned about the clinical-pathologic 
correlations of rejection. In a number of 
patients who become jaundiced postopera-
tively, the homografts are free of mononu-
clear cell invasion, do not have evidence of 
hepatitis, and do not seem obstructed, 
although there is centrilobular cholestasis.2.1I 
Myburg et al. 12 have referred to this as 
cholestatic rejection. In such patients, a pain-
fully slow response to high-dose steroid ther-
Table 4. Blood Group Incompatibility 
Number of cases 
Hyperacute rejection 
Survival > 2 months 
Survival ~ 6 months 
11' 
72t 
8 
at 
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'OT 59. 60. 61; 988.100. 102A. 104. 113. 132.137. 
148A 
t Retransplantation anempted after 17 and 12 days. The 
blood group compatible second grafts were also rejected in 
much the same way as the first. 
* Longest survival-23 months. 
apy can sometimes be obtained. In other 
cases, the penalty for control of such question-
able or even unquestionable rejection with 
high-dose steroid therapy can be fatal infec-
tion, to which liver recipients are especially 
prone because of frequent contamination of 
the homograft with enteric organisms.2.1I·13 
In an effort to reduce steroid requirements 
and to facilitate "graft acceptance," we 
recently treated 9 patients with thoracic duct 
fistula, which was established on the same 
day as liver transplantation in 7 recipients 
and 14 and 26 days postoperatively in 2 
more. 14 Seven of the nine patients are alive, 
including five of the seven who had thoracic 
duct fistulas established on the day of liver 
transplantation. These five patients have 
either had no demonstrable rejection or have 
had mild and rather easily controlled rejec-
tions (Figure 3). So encouraging has been our 
experience with thoracic duct fistula that we 
plan to continue its use on all cases in the 
immediate future. 
SUMMARY 
The development of liver transplantation 
has been made difficult because of the enor-
mous technical di fficulties of the procedure 
and because the postoperative management in 
early cases was defective in many instances. 
With surgical and medical improvements, the 
prospects for success have markedly increased 
recently. The wider use of thoracic duct 
fistula as an adjuvant measure during the first 
1 or 2 postoperative months is being 
explored. 
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